The Newsroom
AdventHealth Among First in U.S. to Offer IDP023-2-101 Clinical Trial for Patients with Progressive Multiple Sclerosis
The AdventHealth Neuroscience Institute is the first in Florida and one of the first in the country to begin recruiting patients with primary progressive or non-active secondary progressive multiple...
AdventHealth Research Contributed to New Method for Tracking Diet and Its Impacts on Human Health
Mayor Demings, AdventHealth on bridging health care gaps
Recent Stories at AdventHealthMD
-
-
Using Genomics and AI to Improve Breast Cancer Risk Assessment and Early Detection
-
New Research Published in New England Journal of Medicine Finds That Adjuvant Pembrolizumab Extends Disease-Free Survival in Muscle-Invasive Urothelial Carcinoma
-
AdventHealth Launches Research Study to Evaluate an Evidence-based Intervention Designed to Address Physician Burnout
-
AdventHealth Physician Team Performs Central Florida’s First Immediate Breast Neurotization After Nipple-sparing Mastectomy
-
AdventHealth Celebration is Among First in the State to Offer Non-invasive Histotripsy Treatment for Unresectable Liver Tumors
-
Breast Cancer Survivor Credits AdventHealth Clinic For Giving Her Hope, Saving Her Life
-
AdventHealth Cancer Institute is Among the First in the World to Offer a New Phase II Clinical Trial of a Novel, Customized Precision Immunotherapy for Patients with High-risk Muscle-invasive Urothelial Carcinoma
-
AdventHealth Waterman Introduces Robotic-Assisted Procedure for Early Lung Cancer Detection